Apogee Therapeutics CEO Sells 15,000 Shares
Meno di 1 minuto di lettura
| Reporter Name | Henderson Michael Thomas |
| Relationship | Chief Executive Officer |
| Type | Sell |
| Amount | $732,692 |
| SEC Filing | Form 4 |
Michael Thomas Henderson, CEO and Director of Apogee Therapeutics, sold 15,000 shares of common stock on January 8, 2025, under a Rule 10b5-1 trading plan. The transactions were executed at weighted average prices of $48.72 and $49.38, with the total sale amounting to $732,692. Following these transactions, Henderson directly owns 1,309,487 shares of Apogee Therapeutics.
SEC Filing: Apogee Therapeutics, Inc. [ APGE ] - Form 4 - Jan. 10, 2025